Holen Sie sich die Stockscreener-App
74.22
0.46%
-0.34
Handel nachbörslich:
74.50
0.28
+0.38%
Überblick
Nachrichten
Preisverlauf
Optionskette
Warum fällt AZN?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Astrazeneca PLC Aktie (AZN) Neueste Nachrichten
3 Magnificent Growth Stocks to Buy Right Now - The Motley Fool
AstraZeneca receives A1 rating upgrade from Moody's, outlook stable By Investing.com - Investing.com Australia
AstraZeneca receives A1 rating upgrade from Moody's, outlook stable - Investing.com
Moody's Lifts AstraZeneca's Ratings, Revises Outlook to Stable -February 21, 2025 at 11:51 am EST - Marketscreener.com
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of AstraZeneca - Business Wire
Levi & Korsinsky Notifies AstraZeneca PLC Investors of a Class Action Lawsuit and Upcoming DeadlineAZN - ACCESS Newswire
2025-02-21 | FINAL REMINDER AZN DEADLINE: Bronstein, Gewirtz & Grossman LLC Alerts AstraZeneca PLC Investors to Participate in the Class Action Lawsuit | NDAQ:AZN | Press Release - Stockhouse Publishing
Meitav Investment House Ltd. Buys 205,000 Shares of AstraZeneca PLC (NASDAQ:AZN) - MarketBeat
Atria Wealth Solutions Inc. Acquires 6,970 Shares of AstraZeneca PLC (NASDAQ:AZN) - MarketBeat
Bryn Mawr Capital Management LLC Has $1.03 Million Holdings in AstraZeneca PLC (NASDAQ:AZN) - MarketBeat
AstraZeneca Target of Unusually Large Options Trading (NASDAQ:AZN) - Defense World
AZN Deadline: AZN Investors Have Opportunity to Lead AstraZeneca PLC Securities Fraud Lawsuit Filed by The Rosen Law Firm - PR Newswire
AstraZeneca PLC (AZN): Among the Best Global Stocks to Buy According to Hedge Funds - Insider Monkey
Final Deadline for the AstraZeneca PLC Securities LawsuitContact the DJS Law Group to Discuss Your RightsAZN - The Malaysian Reserve
FibroGen sells China unit to AstraZeneca for $160m - Pharmaceutical Technology
AstraZeneca Stock: Strategic Expansion in Chinese Market Intensifies - sharewise
Amid Mounting Pressure In China, AstraZeneca Buys FibroGen's Chinese Unit For $160 Million - Benzinga India
US CDC vaccine advisory meeting to be postponed, Stat News reports -February 20, 2025 at 01:06 pm EST - Marketscreener.com
JPMorgan Chase & Co. Reaffirms Overweight Rating for AstraZeneca (LON:AZN) - MarketBeat
AstraZeneca deepens China presence with FibroGen deal - BioPharma Dive
Faruqi & Faruqi Reminds AstraZeneca Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 21, 2025AZN - Morningstar
AstraZeneca PLC Class Action: The Gross Law Firm Reminds AstraZeneca Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 21, 2025AZN - Finansavisen
Here’s Why AstraZeneca PLC (AZN) Traded Lower in Q4 - Insider Monkey
2025-02-20 | Shareholders that lost money on AstraZeneca PLC(AZN) Urged to Join Class ActionContact Levi & Korsinsky to Learn More | NDAQ:AZN | Press Release - Stockhouse Publishing
AstraZeneca to buy FibroGen's China unit for $160 million -February 20, 2025 at 07:04 am EST - Marketscreener.com
FibroGen sells China unit to AstraZeneca for $160 million (FGEN:NASDAQ) - Seeking Alpha
FibroGen sells China unit to AstraZeneca in deal worth $160 million -February 20, 2025 at 06:40 am EST - Marketscreener.com
Catalyst Capital Advisors LLC Has $29,000 Holdings in AstraZeneca PLC (NASDAQ:AZN) - MarketBeat
AstraZeneca (LON:AZN) Given “Overweight” Rating at JPMorgan Chase & Co. - Defense World
2025-02-19 | Shareholders that Lost Money on AstraZeneca PLC (AZN) Should Contact Levi & Korsinsky about Pending Class ActionAZN | NDAQ:AZN | Press Release - Stockhouse Publishing
AstraZeneca Post 2024 Earnings: Unwanted Headwinds Warrant Downgrade To Hold (AZN) - Seeking Alpha
Deadline Soon: AstraZeneca PLC (AZN) Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit - Business Wire
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of AstraZeneca - GlobeNewswire
What's a Good Price for AstraZeneca Stock? - The Motley Fool
Ex-Dividend Reminder: Vestis Corp, ONE Gas and AstraZeneca - Nasdaq
AstraZeneca files annual report with SEC - Investing.com India
AstraZeneca PLC (NASDAQ:AZN) Short Interest Update - MarketBeat
Levi & Korsinsky Alerts AstraZeneca Investors: Lead Plaintiff Deadline for Class Action Lawsuit Approaching on February 21, 2025 - The Octant
Allspring Global Investments Holdings LLC Acquires 93,071 Shares of AstraZeneca PLC (NASDAQ:AZN) - Defense World
AstraZeneca PLC (NASDAQ:AZN) Holdings Raised by Allspring Global Investments Holdings LLC - Defense World
AstraZeneca boss takes home £15m pay packet after profits rise - Insider Media
WealthPlan Investment Management LLC Buys 4,026 Shares of AstraZeneca PLC (NASDAQ:AZN) - MarketBeat
Astrazeneca 'too big to base CEO's pay on peers' -February 19, 2025 at 01:21 am EST - Marketscreener.com
PRESS DIGEST- Financial TimesFeb 19 -February 18, 2025 at 08:41 pm EST - Marketscreener.com
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of AstraZeneca - Markets Insider
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in AstraZeneca PLC. of Class Action Lawsuit and Upcoming DeadlinesAZN - PR Newswire
AstraZeneca PLC Class Action: Levi & Korsinsky Reminds - GlobeNewswire
Investors in AstraZeneca PLC Should Contact Levi & Korsinsky Before February 21, 2025 to Discuss Your RightsAZN - Stockhouse Publishing
AstraZeneca Hit With Us Class Action Lawsuit Over China Regulatory ProbesFT -February 18, 2025 at 01:26 pm EST - Marketscreener.com
AstraZeneca hit with US class action lawsuit over China regulatory probes - Financial Times
Astrazeneca: ‘We’re too big to base our CEO’s pay on FTSE 100 peers’ - Yahoo Finance UK
2025-02-18 | Shareholders that lost money on AstraZeneca PLC (AZN) should contact Levi & Korsinsky about pending Class ActionAZN | NDAQ:AZN | Press Release - Stockhouse Publishing
AstraZeneca PLC (AZN) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - Morningstar
Class Action Filed Against AstraZeneca PLC (AZN) Seeking Recovery for InvestorsContact Levi & Korsinsky - Stockhouse Publishing
AstraZeneca releases annual financial report, sets AGM for April 11 - Investing.com India
astrazeneca announces board changes ahead of AGM - Investing.com India
AZN Investors Have Opportunity to Lead AstraZeneca PLC Securities Fraud Lawsuit with the Schall Law Firm - Finansavisen
Capital Group Increases Stake in AstraZeneca - TipRanks
AstraZeneca (LON:AZN) Has Announced That It Will Be Increasing Its Dividend To $1.68 - Simply Wall St
AstraZeneca releases 2024 annual financial report - Investing.com
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 21, 2025 in AstraZeneca LawsuitAZN - Longview News-Journal
AstraZeneca Releases 2024 Annual Financial Report - TipRanks
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):